Webcasts
LC-MS Analysis of Adeno-Associated Virus Critical Quality Attributes
May 11th 2021*Tuesday, May 11, 2021 at 9am EDT | 2pm BST | 3pm CEST, Tuesday, May 11, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Adeno-associated viruses (AAVs) are an important tool enabling the delivery of next-generation gene therapies. *Available On Demand Until May 11, 2022*
Using AI for CAPA and Root-Cause Investigations
May 6th 2021*Thursday, May 6, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Learn how artificial intelligence can be used to investigate corrective and preventive actions, pinpoint the root cause of the most common complaints, tell if training is effective, and identify the combination of materials and workers to increase production. *On Demand Until May 6, 2022*
Bioprocess Cleaning Best Practices: Raw Materials vs. Blended Detergents
April 27th 2021***Live: Tuesday, April 27, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST** This webcast will intensively discuss differences between cleaning using commodity chemicals and blended detergents. Real-life examples—including discussion on cleaning of fermentation residues and processing aids—will illustrate cleaning challenges in the biotechnology industry. *On Demand until April 27, 2022*
Ultra-fast Analysis of Intact Proteins and Oligonucleotides Using High-Throughput Mass Spectrometry
April 26th 2021***Live: Monday, April 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Analytical characterization of biomolecules can be challenging because impurities from the synthesis, expression, and degradation of the intended product make the samples complex. Discover the latest innovations, using high-throughput mass spectrometry, to streamline workflows, and simplify complicated analysis, increase throughput, and accelerate bringing biomolecules to market.***On Demand until Apr. 26, 2022***
Technology Forum Series: Strategies to Prevent Drug Shortages and Resolve Capacity Challenges.
***Session 1: Thursday, April 22, 2021, 10am EDT, Session 2: Thursday, April 22, 2021, 11am EDT, Session 3: Thursday, April 22, 2021, 1pm EDT*** A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.
Designing Stability Programs for Drug Substances and Products
April 13th 2021***Live Tuesday, April 13, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST** Designing a successful stability program can go a long way towards getting your drug product or substance to market. Join this webinar to receive guidance on designing stability testing programs and overcoming potential challenges. *On Demand until April 13, 2022*
Profiling the HLA-II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Using Mass Spectrometry.
March 30th 2021***Available Now!*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*
Leveraging the Power of a Core-Shell LC Particle to Improve Micro and Nano Flow Separations
March 29th 2021***Live: Monday, March 29, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** In order to achieve the required sensitivity when working with small samples sizes, such as in the case of proteomic or metabolomic analysis, a low flow rate LC column is required. Micro and nano LC provides a practical solution for labs and along with the added advantage of core-shell particles, the sensitivity needs are exceeded. ***On Demand until Mar. 29, 2022***
Hydrogen–Deuterium Exchange Coupled with Cyclic Ion Mobility for Higher Quality Analyses
March 25th 2021*Thursday, March 25, 2021 at 10am EDT| 7am PDT| 2pm GMT| 3pm CET* Join us to learn how to address challenges with screening protein complexes using hydrogen–deuterium exchange and cyclic ion-mobility MS. *On demand available after final airing until March 25, 2022*
Elevating Your Charge Variant and Aggregate Analysis for Biotherapeutic Proteins
March 22nd 2021*Monday, March 22, 2021 at 9am EDT| 1pm GMT | 2pm CET, Monday, March 22, 2021 at 2pm EDT| 1pm CDT | 11am PDT* High resolution is one of the key challenges in modern biopharmaceutical analysis. In this webinar learn the importance of considering the entire liquid chromatography (LC) system to gain optimum results and maximum resolution from your LC column. *On demand available after final airing until March 22, 2022*
A Material Characterization Study for AAV Process Development and Tool Selection
March 17th 2021***Live: Wednesday March 17, 2021 at 11am EDT| 8am PDT| 4pm GMT| 5pm CET *** Single-use material selection is a crucial element of process development for bioprocessing, and emerging viral vector-based therapies have special requirements. Learn about efforts to better understand the relationship of single-use material selection and process impact to improve yield. ***On Demand until March 17, 2022***
Analytical Tools for PAT Implementation for the characterization of Biosimilars.
March 9th 2021***Live: Europe Broadcast: Tuesday, March 9, 2021 at 9am EST | 2pm GMT | 3pm CET US Broadcast: Tuesday, March 9, 2021 2pm EST | 1pm CST | 11am PST*** This event will aim to present an overview of how analytical technologies can be adapted for implementation of Process Analytical Technology (PAT) in bioprocessing and how this can result in effective process control, thereby delivering consistent process performance and product quality.
Characterization of Next Generation Antibody-Drug Conjugates (ADCs) by Mass Spectrometry
March 2nd 2021*Live Date: Tuesday, March 2, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET* In this webinar, you will learn how LC-MS has been broadly leveraged to accelerate the development of antibody-drug conjugates (ADCs). *Available On Demand Until March 2, 2022*
The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference
February 24th 2021***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET*** Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***
Profiling the HLA-II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Using Mass Spectrometry
February 23rd 2021***Live: Tuesday, Feb. 23, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until Feb. 23, 2022*
Quantitative LC–MS Workflow for Cell Culture Media Monitoring
January 20th 2021***Live: Wednesday, January 20, 2021 at 11am EST | 8am PST | 4 pm GMT | 5pm CET *** Cell culture media (CCM) optimization is a critical step during the development and scale up of biotherapeutic manufacturing process. In particular, the emphasis on quality by design has made it necessary to understand how the components of CCM change during production and how these changes relate to product quality. In this webcast, learn how targeted cell-culture media workflow can help scientists understand growth media for biotherapeutics and improve their manufacturing process. ***On demand available after final airing until Jan. 20, 2022***
Expediting Biologics Drug Development: Strategies to Accelerate Preclinical Development Timelines
December 3rd 2020***Live: Thursday, Dec. 3, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** Review preclinical strategies to improve drug development outcomes for biologic drugs, including innovative solutions and risk-based approach to expedite investigational new drug submissions, especially for pandemic response initiatives.. ***On demand available after final airing until Dec. 3, 2021***
Advancement in Single-Use Sensor Technology for Mammalian and Microbial Bioprocesses
December 2nd 2020***Live: Wednesday, December 2, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Learn more about the recent trends in single-use sensors to match bioprocessing needs of bioreactor, fermenters, and mixing applications. Review data from 2-year studies of sensor testing.***On demand available after final airing until Dec. 2, 2021***
2020 Bio/Pharma Virtual Congress
*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021***
Intact and Subunit MAM Assays Accelerate the Development of Antibody-Drug Conjugates
October 8th 2020***Live: Tuesday, November 3, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET*** In this webcast, learn how multi-attribute assays were used to accelerate routine workflows for biotherapeutics characterization at the intact and subunit level. This new streamlined approach increased the efficiency to perform stability assessment of antibody-drug onjugates (ADC) significantly.***On demand available after final airing until Nov. 3, 2021***
Characterization of Viral Vector Particles with LC–MS
October 1st 2020*** Two Live Events! Monday, Oct. 26, 2020 at 9am EDT| 1pm GMT| 2pm CET and Monday, Oct. 26, 2020 at 2pm EDT| 1pm CDT| 11am PDT*** Join us for this web seminar to learn about the utility of mass spectrometry for characterizing adeno-associated viruses (AAVs), including how intact mass spectrometry can accurately confirm AAV capsid proteins, how AAV post-translational modifications can be identified and confirmed, and how upfront sample preparation can improve mass spec accuracy and resolution. ***On demand available after final airing until Oct. 26, 2021***
Breakthroughs in FFF-MALS – New Levels of Performance and Usability
September 28th 2020*** Three Events: Tuesday, Oct. 27, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET Asia Pacific: Wednesday, Oct. 28, 2020 at 10:30 am IST| 1pm CST| 2pm JST Europe: Wednesday, Oct. 28, 2020 at 9am| 10am CET*** Characterizing complex nanoparticles, polymers and biotherapeutics is about to get a lot easier. ***On demand available after final airing until Oct. 28, 2021***
Vero Cell Cultivation for Vaccine Production
September 27th 2020***Live: Thursday, Oct. 22, 2020 at 10am EDT| 9am CDT| 3pm BST| 4pm CEST***Process development for anchorage-dependent cells at bench scale is crucial to establish cost-efficient workflows in larger volumes. Learn how different process parameter can be monitored and controlled in a perfusion bioprocess and the potential of using packed-bed bioreactors or a microcarrier spin filter for attachment cell-based vaccine production.. *** On demand available after final airing until Oct. 22, 2021.***
Host Cell Proteins: Analytical and Regulatory Challenges
September 27th 2020***Live: Wednesday, Oct. 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Host cell proteins (HCPs) can compromise a biologic drug and delay its development program. Learn about important considerations for optimizing HCP testing in this webcast. ***On demand available after final airing until Oct. 21, 2021***
